Skip to main content
Log in

Pharmacological treatment of reflex syncope

  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract.

Patient education, identification of possible triggers of syncope and reassurance are a central feature of the management of patients with reflex syncope. Patients should be advised as to the importance of adequate hydration and taught physical countermaneuvers to enhance cardiac venous return. These maneuvers are sufficient for most patients, however, for a small number of patients who continue to have recurrent syncopal events, pharmacological intervention may be considered. Volume expansion can be enhanced with salt and fludrocortisone. Agents from diverse pharmacological classes have been used to attenuate the reflex response, enhance vasoconstriction and attenuate vagal outflow. Alpha adrenoreceptor agonists, anticholinergic agents, theophylline, beta adrenoreceptor antagonists, serotonin reuptake inhibitors and disopyramide are the most widely studied. None of these agents has shown a consistent therapeutic benefit in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alegria JR, Gersh BJ, Scott CG, Hodge DO, Hammill SC, Shen WK (2003) Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 92:82–84

    Article  PubMed  Google Scholar 

  2. Benditt DG, Benson DW Jr, Kreitt J, Dunnigan A, Pritzker MR, Crouse L, Scheinman MM (1983) Electrophysiologic effects of theophylline in young patients with recurrent symptomatic bradyarrhythmias. Am J Cardiol 52:1223–1229

    Article  CAS  PubMed  Google Scholar 

  3. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Moya A, Raviele A, Sutton R, Theodorakis G, Wieling W (2001) Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 22:1256–1306

    Article  PubMed  Google Scholar 

  4. Brignole M, Gaggioli G, Menozzi C, Gianfranchi L, Bartoletti A, Bottoni N, Lolli G, Oddone D, Del Rosso A, Pellinghelli G (1997) Adenosine-induced atrioventricular block in patients with unexplained syncope: the diagnostic value of ATP testing. Circulation 96:3921–3927

    CAS  PubMed  Google Scholar 

  5. Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227–1230

    Article  CAS  PubMed  Google Scholar 

  6. Dietz NM, Engelke KA, Samuel TT, Fix RT, Joyner MJ (1997) Evidence for nitric oxide-mediated sympathetic forearm vasodilatation in humans. J Physiol 498:531–540

    CAS  PubMed  Google Scholar 

  7. Dietz NM, Halliwill JR, Spielmann JM, Lawler LA, Papouchado BG, Eickhoff TJ, Joyner MJ (1997) Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol 82:1785–1793

    CAS  PubMed  Google Scholar 

  8. Ehringer H (1971) Study of human peripheral hemodynamics after i. v. infusion of a small dosage of dl-1-(2’,5’-dimethoxyphenyl)-2-glycinamidoethanol-(1) hydrochloride (= st 1085). Int Z Klin Pharmakol Ther Toxikol 4:415–420

    CAS  PubMed  Google Scholar 

  9. El-Sayed H, Hainsworth R (1995) Relationship between plasma volume, carotid baroreceptor sensitivity and orthostatic tolerance. Clinical Science 88:463–470

    CAS  PubMed  Google Scholar 

  10. El-Sayed H, Hainsworth R (1996) Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75:134–140

    CAS  PubMed  Google Scholar 

  11. Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT (2002) Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being. J Am Coll Cardiol 40:499–504

    Article  CAS  PubMed  Google Scholar 

  12. Jacob G, Robertson D, Mosqueda Garcia R, Ertl AC, Robertson RM, Biaggioni I (1997) Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 103:128–133

    Article  CAS  PubMed  Google Scholar 

  13. Kaufmann H, Berman J, Oribe E, Oliver J (1993) Possible increase in the synthesis of endothelial derived relaxing factor (EDRF) during vasovagal syncope. Clin Auton Res 3:69 (Abs)

    Google Scholar 

  14. Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J (1988) Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 38:951–956

    CAS  PubMed  Google Scholar 

  15. Kaufmann H, Saadia D, Voustianiouk A (2002) Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 52:342–345

    Article  CAS  PubMed  Google Scholar 

  16. Lee TM, Su SF, Chen MF, Liau CS, Lee YT (1996) Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78:480–482

    Article  CAS  PubMed  Google Scholar 

  17. Lewis T (1932) Lecture on vasovagal syncope and the carotid sinus mechanism. Br Med J 1:873–876

    Google Scholar 

  18. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 277:1046–1051

    Article  CAS  PubMed  Google Scholar 

  19. Madrid AH, Ortega J, Rebollo JG, Manzano JG, Segovia JG, Sanchez A, Pena G, Moro C (2001) Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 37:554–559

    Article  CAS  PubMed  Google Scholar 

  20. Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130:1250–1253

    Article  CAS  PubMed  Google Scholar 

  21. Milstein S, Buetikofer J, Lesser J, Goldenberg IF, Benditt DG, Gornick C, Reyes WJ (1989) Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia (see comments). J Am Coll Cardiol 14:1626–1632

    CAS  PubMed  Google Scholar 

  22. Morillo C, Leitch J, Yee R, Klein G (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22:1843–1848

    CAS  PubMed  Google Scholar 

  23. Morillo CA, Klein GJ, Gersh BJ (1996) Can serial tilt testing be used to evaluate therapy in neurally mediated syncope? Am J Cardiol 77:521–523

    Article  CAS  PubMed  Google Scholar 

  24. Nelson SD, Stanley M, Love CJ, Coyne KS, Schaal SF (1991) The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 151:2425–2429

    Article  CAS  PubMed  Google Scholar 

  25. Oribe E, Kaufmann H, Winters S, Gomes J (1992) Fludrocortisone versus Beta-Adrenergic Blockers in the treatment of vasovagal syncope. Neurology 42:213

    Google Scholar 

  26. Pollick C (1995) Effects of disopyramide on diastolic function in hypertrophic cardiomyopathy. Am J Cardiol 75:652

    CAS  Google Scholar 

  27. Ramsdell CD, Mullen TJ, Sundby GH, Rostoft S, Sheynberg N, Aljuri N, Maa M, Mukkamala R, Sherman D, Toska K, Yelle J, Bloomfield D, Williams GH, Cohen RJ (2001) Midodrine prevents orthostatic intolerance associated with simulated spaceflight. J Appl Physiol 90:2245–2248

    CAS  PubMed  Google Scholar 

  28. Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 99:1452–1457

    CAS  PubMed  Google Scholar 

  29. Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE (2001) Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 285:52–59

    Article  CAS  PubMed  Google Scholar 

  30. Scott WA, Pongiglione G, Bromberg BI, Schaffer MS, Deal BJ, Fish FA, Dick M (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402

    Article  CAS  PubMed  Google Scholar 

  31. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 78:536–539

    Article  CAS  PubMed  Google Scholar 

  32. Sinkovec M, Grad A, Rakovec P (2001) Role of endogenous adenosine in vasovagal syncope. Clin Auton Res 11:155–161

    CAS  PubMed  Google Scholar 

  33. Takata TS, Wasmund SL, Smith ML, Li JM, Joglar JA, Banks K, Kowal RC, Page RL, Hamdan MH (2002) Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 106:1500–1504

    Article  CAS  PubMed  Google Scholar 

  34. Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45–49

    CAS  PubMed  Google Scholar 

  35. Wieling W, Van Lieshout JJ, Hainsworth R (2002) Extracellular fluid volume expansion in patients with posturally related syncope. Clin Auton Res 12:242–249

    Article  CAS  PubMed  Google Scholar 

  36. Wright RA, Kaufmann HC, Perera R, Opfer-Gehrking TL, McElligott MA, Sheng KN, Low PA (1998) A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51:120–124

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Horacio Kaufmann MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaufmann, H., Freeman, R. Pharmacological treatment of reflex syncope. Clin Auton Res 14 (Suppl 1), i71–i75 (2004). https://doi.org/10.1007/s10286-004-1010-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10286-004-1010-4

Key words

Navigation